A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults
JAMA Network Open · 08.10.2025 · 8 (10) · e2535813
DOI: 10.1001/jamanetworkopen.2025.35813 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 08.10.2025. Verfasst von Zixin Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Health Behaviours Research, JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Pneumococcal Infections, Vaccination, Health Promotion. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Importance There are few robust evaluations assessing the efficacy of chatbots to improve pneumococcal vaccination (PV) uptake among adults 65 years of age or older.
Objective
To evaluate the relative efficacy of a hybrid chatbot in increasing PV uptake among Hong Kong residents aged 65 years or older. Design, Setting, and Participants This partially masked, parallel-group randomized clinical trial was conducted between May 1, 2023, and November 30, 2024 in Hong Kong, China. Participants were aged 65 years or older, had a Hong Kong identity card, could speak and comprehend Cantonese, were smartphone and WhatsApp users, and had no prior PV uptake. Participants were recruited through random telephone calls and were randomized to either the stage of change group or the standard intervention group.
Interventions
In the stage of change group, the rule-based component of the hybrid chatbot assessed participants’ stage of change regarding PV uptake and then delivered stage of change–tailored interventions at months 0, 1, 2, and 3. The natural language processing component of the hybrid chatbot provided real-time answers to participants’ PV-related questions. In the standard intervention group, the chatbot sent participants a link to access a standard online video covering PV information at months 0, 1, 2, and 3. Main Outcomes and Measures The primary outcome was self-reported PV uptake at month 12, which was validated by the research team. The secondary outcome was participants’ stage of change measured at month 0 and month 12 by using validated questions, with a score of 1 = precontemplation, 2 = contemplation, 3 = preparation, and 4 = action.
Results
A total of 374 participants (213 female [57.0%]; mean [SD] age, 69.6 [3.1] years) were randomized to either the stage of change group (n = 187) or the standard intervention group (n = 187). The intention-to-treat analysis showed that the validated PV uptake rate was higher in the stage of change group than in the standard intervention group (29.4% vs 18.7%; P = .01). The mean (SD) stage of change score was higher in the stage of change group than in the standard intervention group (2.2 [1.3] vs 1.9 [1.1]; P = .02). More participants in the stage of change group than in the standard intervention group completed at least 1 intervention session (79.7% vs 57.8%; P < .001). Conclusions and Relevance In this randomized clinical trial, the hybrid chatbot was more efficacious than the standard intervention in increasing PV uptake among older adults in Hong Kong. A hybrid chatbot may be a sustainable PV promotion for older adults. Trial Registration ClinicalTrials.gov Identifier: NCT05772117
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Health Behaviours Research, JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong SAR, China.
- School of Computer Science, the University of Sydney, Sydney, New South Wales, Australia.
- School of Computing and Information System, the University of Melbourne, Melbourne, Victoria, Australia.
- Department of Health and Physical Education, the Education University of Hong Kong, Hong Kong SAR, China.
- School of Nursing, Yale University, New Haven, Connecticut.
- Centre for Interdisciplinary Research on AIDS (CIRA), Yale University, New Haven, Connecticut.
Zitieren
APA
Wang, Z., Chen, S., Poon, J., Han, S. C., Ye, D., Yu, F. Y., Fang, Y., Ni, Z., Wong, M. C. S., & Mo, P. K. H. (2025). A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults. JAMA Network Open, 8(10), e2535813. https://doi.org/10.1001/jamanetworkopen.2025.35813
Vancouver
Wang Z, Chen S, Poon J, Han SC, Ye D, Yu FY, et al. A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults. JAMA Network Open. 2025;8(10):e2535813. doi:10.1001/jamanetworkopen.2025.35813
BibTeX
@article{Wang2025,
author = {Wang, Zixin and Chen, Siyu and Poon, Josiah and Han, Soyeon Caren and Ye, Danhua and Yu, Fuk-Yuen and Fang, Yuan and Ni, Zhao and Wong, Martin C S and Mo, Phoenix K H},
title = {A Hybrid Chatbot to Promote Pneumococcal Vaccination Among Older Adults},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {10},
pages = {e2535813},
doi = {10.1001/jamanetworkopen.2025.35813}
}
EUVIMED